Luohe Huichuang Pharmaceutical

Luohe Huichuang Pharmaceutical is a Chinese pharmaceutical company founded in 2023 and based in Luohe, Henan Province. The company operates primarily as a Marketing Authorization Holder (MAH), utilizing a business model that involves entrusted research and development and manufacturing through strategic partnerships. Its product portfolio focuses on chemical drugs across several therapeutic areas, including gastroenterology, electrolyte management, and maternal health. Key products in its pipeline and commercial portfolio include Magnesium Sulfate Injection, Prucalopride Succinate Tablets, and Sodium Bicarbonate Injection. The company collaborates with partners such as Zhejiang Heze Pharmaceutical and Yusongyuan Pharmaceutical to bring its products to the Chinese market.